You are here

Mesenchymal Stromal Cells Anno 2019

A recently published Concise Review from Martin J. Hoogduijn (Erasmus Medical Center, Rotterdam, The Netherlands) and Eleuterio Lombardo (Cell Therapy Technology Center, Madrid, Spain) provides an overview of the considered mechanism of action of mesenchymal stromal cells (MSCs) and the status of the development of MSC therapy as of 2019. Writing in STEM CELLS Translational Medicine, the authors note that the increased interest in the therapeutic use of MSCs and the ongoing elucidation of the mechanisms of action of MSCs represent promising indicators that 2019 may be the dawn of the therapeutic era of MSCs and that there will be revived interest in research to develop more efficient, practical, and sustainable MSC‐based therapies.